Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes

Clinical Chemistry

Volumn 47, Issue 3, 2001, Pages 505-512

  Miyashiro, I ^a   Kuo, C ^a   Huynh, K ^a   Iida, A ^a   Morton, D ^a   Bilchik, A ^a   Giuliano, A ^a   Hoon, D S B ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOMA ANTIGEN; MELANOMA ASSOCIATED ANTIGEN FAMILY A; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CHEMOLUMINESCENCE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENE ISOLATION; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; NUCLEOTIDE SEQUENCE; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

EID: 0035107378     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.3.505     Document Type: Article

References (35)

1. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay
2. Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence
3. Utilization of polymerase chain reaction technology in the detection of solid tumors
4. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer
5. Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients
6. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection
7. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients
8. Prognostic importance of occult axillary lymph node micrometastases from breast cancers
9. Molecular staging of early colon cancer on the basis of sentinel node analysis: A multicenter phase II trial
10. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
11. Melanoma-associated antigens as messenger RNA detection markers for melanoma
12. Comparative decreases in tyrosinase, TRP-1, TRP-2, and Pmel 17/silver antigenic proteins from melanotic to amelanotic stages of syngeneic mouse cutaneous melanomas and metastases
13. Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors
14. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction
15. High frequency of expression of MAGE genes in human hepatocellular carcinoma-
16. The expression of tumor-rejection antigen; genes in human gastric carcinoma
17. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
18. Structure, chromosomal localization, and expression of 12 genes of the MAGE family
19. Expression of MAGE genes in primary and metastatic cutaneous melanoma
20. Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes
21. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder
22. Expression of the MAGE gene family in primary and metastatic human breast cancer: Implications for tumor antigen-specific immunotherapy
23. Expression of mage genes by non-small-cell lung carcinomas
24. Expression of MAGE and BAGE genes in Japanese breast cancers
25. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma
26. CT10: A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis
27. Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay
28. Detection of occult tumor cells in the blood of breast cancer patients using a molecular detection assay
29. Detection of tyrosinase mRNA in melanoma by reverse transcription-PCR and electrochemiluminescence
30. Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
31. Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine
32. A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion
33. Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family
34. Induction of melanoma-associated antigen systemic immunity on intratumor delivery of interferon-T retroviral vector in melanoma patients
35. Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen